About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Aptxtm1Pmc
targeted mutation 1, Peter J McKinnon
MGI:3686875
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Aptxtm1Pmc/Aptxtm1Pmc 129S4/SvJae MGI:3687171
cx2
Aptxtm1Pmc/Aptxtm1Pmc
Atmtm2.1Mfgc/Atmtm2.1Mfgc
involves: 129 * C57BL/6 MGI:6836754
cx3
Aptxtm1Pmc/Aptx+
Atmtm2.1Mfgc/Atmtm2.1Mfgc
involves: 129 * C57BL/6 MGI:6836762


Genotype
MGI:3687171
hm1
Allelic
Composition
Aptxtm1Pmc/Aptxtm1Pmc
Genetic
Background
129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aptxtm1Pmc mutation (1 available); any Aptx mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• following exposure to methylmethanesulphonate, astrocytes exhibit short-patch repair compared with wild-type cells
• astrocytes fail to support short-patch repair of adenylated oxidative single strand breaks unlike wild-type cells
• following treatment with hydrogen peroxide and aphidicolin, single strand break repair in astrocytes is slowed compared to in similarly treated wild-type cells
• however, primary quiescent astrocytes and cerebellar granule neurons treated with MMS or hydrogen peroxide exhibit normal single strand break repair

homeostasis/metabolism
• following exposure to methylmethanesulphonate, astrocytes exhibit short-patch repair compared with wild-type cells
• astrocytes fail to support short-patch repair of adenylated oxidative single strand breaks unlike wild-type cells
• following treatment with hydrogen peroxide and aphidicolin, single strand break repair in astrocytes is slowed compared to in similarly treated wild-type cells
• however, primary quiescent astrocytes and cerebellar granule neurons treated with MMS or hydrogen peroxide exhibit normal single strand break repair




Genotype
MGI:6836754
cx2
Allelic
Composition
Aptxtm1Pmc/Aptxtm1Pmc
Atmtm2.1Mfgc/Atmtm2.1Mfgc
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aptxtm1Pmc mutation (1 available); any Aptx mutation (22 available)
Atmtm2.1Mfgc mutation (0 available); any Atm mutation (169 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice show reduced survival, with 53% of mice still alive at 400 days of age compared to 97% survival in wild-type controls

growth/size/body
• mice weigh about 35% less than controls
• adolescent mice at P45 weigh on average 30% less in males and 25% in females than controls
• mice grow approximately 55% slower and reach plateau weights that are about 35% less than controls

behavior/neurological
• motor coordination defects emerge between 210 and 400 days after birth
• differences in motor function are first detectable at P8, where mice take 3-4 times longer on average to right themselves
• mice develop severe and progressive ataxia
• mice take twice as long to descend the vertical pole at P400 compared to controls
• mice show a slower cadence and average speed across the gait platform at P400
• mice at P400, but not P210, need additional stabilization during ambulation, as they spend twice as much time with 3 paws rather than the normal 2, in contact with the ground as they walk across the gait analysis platform

neoplasm

nervous system
• somatic size of the Purkinje neurons is reduced
• the primary and secondary dendrites of Purkinje neurons are abnormally large in caliber
• the molecular layer width is normal in younger mice but progressively decreases in width at severity of ataxia increases
• however, no difference in the width of the granule cell layer is seen
• cerebellar atrophy develops as ataxia severity increases; cerebellum size is normal before P210, but by P210 the size is reduced, with continuing degenerative process to P460
• cerebellar atrophy is associated with selective reduction in the width of the molecular layer where Purkinje neuron dendrites reside
• cerebellar atrophy is not due to Purkinje neuron cell death as Purkinje neuron density is not different
• cerebellar neurodegeneration begins after P120
• mice exhibit deficits in the ability of Purkinje neurons to fire continuously in response to current, with perturbations in the amplitude, threshold, and area of evoked action potentials
• Purkinje neurons show reduced spontaneous firing frequency; although slower Purkinje neuron firing rate is seen across most regions of the cerebellum, some subregions appear less impacted, including some areas of the lateral cerebellum, including the paraflocculus, paramedian, and crus I and II
• the most significant firing frequency decline occurs between P120 and 210
• Purkinje neurons exhibit tighter membranes, displaying higher membrane input resistances and a faster membrane time constant, indicating a reduced total membrane capacitance
• climbing fiber-to-Purkinje neuron synaptic responses depress at significantly greater magnitudes, with smaller overall width and decay time constant of the evoked currents
• however, synaptic properties of parallel fibers are normal, with no differences in short-term facilitation or halfwidth and decay time constant
• spontaneous excitatory postsynaptic current (sEPSC) frequency is increased in granule cell-to-Purkinje neuron synapses
• however, mice show no difference in spontaneous excitatory postsynaptic current (sEPSC) size generated by granule cell-to-Purkinje neuron synapses, indicating the function of granule cell axon terminals (parallel fiber inputs) is normal in the cerebellum

immune system
• mice exhibit elevated proportions of CD44+CD25- (DN1 stage), CD44+CD25+ (DN2 stage), and CD44-CD25+ (DN3 stage) cells and lower CD44-CD25- (DN4 stage), indicating an impediment of CD44-CD25+ cells maturing into CD44-CD25- double negative cells
• the proportion of CD8+ T-cells is increased
• reduction in the total fraction of CD3+ T-cells in the peripheral blood
• reduction in the percentage of T-cells is peripheral blood is mostly associated with a reduction in the CD4+ helper T-cell population

hematopoietic system
• mice exhibit elevated proportions of CD44+CD25- (DN1 stage), CD44+CD25+ (DN2 stage), and CD44-CD25+ (DN3 stage) cells and lower CD44-CD25- (DN4 stage), indicating an impediment of CD44-CD25+ cells maturing into CD44-CD25- double negative cells
• the proportion of CD8+ T-cells is increased
• reduction in the total fraction of CD3+ T-cells in the peripheral blood
• reduction in the percentage of T-cells is peripheral blood is mostly associated with a reduction in the CD4+ helper T-cell population

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ataxia telangiectasia DOID:12704 OMIM:208900
J:316365




Genotype
MGI:6836762
cx3
Allelic
Composition
Aptxtm1Pmc/Aptx+
Atmtm2.1Mfgc/Atmtm2.1Mfgc
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aptxtm1Pmc mutation (1 available); any Aptx mutation (22 available)
Atmtm2.1Mfgc mutation (0 available); any Atm mutation (169 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice exhibit reduced survivability with 52% of mice still alive at 400 days of age

neoplasm





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory